FLOT1 and multiple sclerosis: In conclusion, although we found six patients with autoantibodies against the FLOT-1/2 complex and one patient with autoantibodies against ANO2 protein, it is not clear if they associate with a specific disease subset or whether these antibodies play a role in multiple sclerosis pathogenesis or represent a non-pathogenic epiphenomenon.